A recent study assessed the effectiveness of guideline-recommended therapies for Parkinson disease patients, including physiotherapy and occupational therapy.
The FDA has approved new options for lower limb spasticity, relapsed multiple myeloma, and diabetic foot ulcers that healthcare professionals should be aware of.
Investigators involved in the ongoing Parkinson’s Progression Markers Initiative study are aiming to define biomarkers of Parkinson disease diagnosis and progression. Here is what their latest analysis...
A study investigated the neural mechanisms behind aggressive behaviors in patients with Alzheimer disease and amnestic mild cognitive impairment, revealing distinct associations between brain activity and...
Researchers found that approximately 1 in 7 patients with aquaporin-4 antibody positive (AQP4-IgG+) neuromyelitis optica spectrum disorder (NMOSD) experienced neurologic symptoms before their first attack.
...
A team led by researchers is working on a treatment they say has potential to offer benefits on par with the best motion sickness treatments available.
